TRIVALENT TICK FEVER VACCINE

Country: Australia

Language: English

Source: APVMA (Australian Pesticides and Veterinary Medicines Authority)

Active ingredient:

BABESIA BIGEMINA; BABESIA BOVIS; ANAPLASMA CENTRALE

Available from:

DEPARTMENT OF AGRICULTURE AND FISHERIES

INN (International Name):

Babesia bigemina(2500000u/dose)+Babesia bovis(10000000u/dose) + others

Pharmaceutical form:

MISC. VACCINES OR ANTI SERA

Composition:

BABESIA BIGEMINA VACCINE-MICROBIAL Active 0.0 P; BABESIA BOVIS VACCINE-MICROBIAL Active 0.0 P; ANAPLASMA CENTRALE VACCINE-VIRAL Active 0.0 P

Units in package:

100mL; 200mL; 20mL; 40mL; 50mL

Class:

VP - Veterinary Pesticide

Manufactured by:

DEPT AGRICULTURE, FI

Therapeutic group:

CATTLE | BEEF | BOS INDICUS | BOS TAURUS | BOVINE | BUFFALO | BULL | BULLOCK | CALF | COW | DAIRY COW | HEIFER | STEER

Therapeutic area:

IMMUNOTHERAPY

Therapeutic indications:

TICK FEVER - BOVINE ANAPLASMOSIS | TICK FEVER - BOVINE BABESIOSIS | VACCINE | ANAPLASMA MARGINALE | BABESIA BIGEMINA | BABESIA BOVIS | EQUINE ROTAVIRUS | RED WATER | REDWATER

Product summary:

Poison schedule: 0; Withholding period: WHP: Nil; Host/pest details: CATTLE: [TICK FEVER - BOVINE ANAPLASMOSIS, TICK FEVER - BOVINE BABESIOSIS, VACCINE]; For control of tick fever (Babesiosis & Anaplasmosis) in cattle.Vaccination of pregnant cattle and adult bulls must be carried out at the owner's risk in view of known complications that can arise when vaccinating these classes of stock. OTHER PRECAUTIONS, etc: SEE LABEL.

Authorization status:

Registered

Authorization date:

2023-07-01

Patient Information leaflet

DEPARTMENT OF AGRICULTURE, FISHERIES AND FORESTRY
TRIVALENT TICK FEVER VACCINE
49716/104767
COMPANY NAME:
PRODUCT NAME:
APVMA APPROVAL NO:
LABEL NAME:
Trivalent Tick Fever Vaccine
SIGNAL HEADINGS:
FOR ANIMAL TREATMENT ONLY
CONSTITUENT
STATEMENTS:
Each 2ml dose contains live attenuated strains of tick fever
organisms:
1 x 10^7 Babesia bovis organisms
1 x 10^7 Anaplasma centrale organisms
2.5 x 10^6 Babesia bigemina organisms
CLAIMS:
For control of tick fever (babesiosis and anaplasmosis) in cattle.
One vaccination is usually sufficient to provide life-long immunity
against natural tick
fever infections. Immunity to all three parasites develops within
approximately 8 weeks of
administration of the vaccine
NET CONTENTS:
100mL
200mL
20mL
40mL
50mL
DIRECTIONS FOR USE:
Just a heading
PRECAUTIONS:
• If possible, avoid using simultaneously with other vaccines. Use
other vaccines 2 weeks
before or 4 weeks after tick fever vaccine.
• Avoid use of tick fever vaccine for at least 8 weeks after
administration of imidocarb,
(e.g.Imizol or Imidox).
• Monitor vaccinated cattle closely during reaction periods if over
9 months of age,
especially bulls and pregnant cattle (see monitoring and control of
vaccine reactions).
• Vaccination of pregnant cattle and adult bulls must be carried out
at the owner’s risk in
view of complications that can arise when vaccinating these classes of
stock.
• Cattle older than 9 months with no previous immunity run the risk
of disease from
concurrent field infections for at least 4 weeks after vaccination for
Babesia or up to 8
weeks for Anaplasma.
• Carcass quality could be affected by fever during vaccine reaction
periods. RLP APPROVED
DOSAGE AND
ADMINISTRATION:
• Mix vaccine gently before use.
• Use all product immediately upon opening.
• Do not use vaccine that is not cool on arrival (less than 20ºC).
• Dose is 2mL per animal regardless of age or body weight.
• Give by subcutaneous or intramuscular injection only.
GENERAL DIRECTIONS:
• Safe to use with anthelmintics (dr

Summary of Product characteristics

_TICK FEVER CENTRE, WACOL _
_MSDS TRIVALENT _
MATERIAL SAFETY DATA SHEET
TRIVALENT TICK FEVER VACCINE
_REF: MSDS 3 _
_ _
_ _
Rev: 8
Date of Issue: 17/01/11
Page 1 of 5
Department of Employment, Economic Development & Innovation
Biosecurity
Tick Fever Centre
280 Grindle Road, Wacol Queensland 4076 Australia
Telephone: [phone]
Fax: [phone]
E-mail: [e-mail]
Web-site: www.biosecurity.qld.gov.au
(search for ‘tick fever’)
IDENTIFICATION
PRODUCT NAME
:
TRIVALENT
TICK FEVER VACCINE
OTHER NAMES:
Trivalent chilled vaccine
MANUFACTURER’S PRODUCT CODE
:
TRV/10, 20, 25, 50, 100.
UN NUMBER:
None allocated
DANGEROUS GOODS CLASS AND
None allocated, no subsidiary risk
SUBSIDIARY RISK
HAZCHEM CODE:
None allocated
POISONS SCHEDULE NUMBER:
Not scheduled
USE:
For control of Tick Fever (Bovine Babesiosis and
Anaplasmosis)
by vaccination in cattle.
PHYSICAL DESCRIPTION/PROPERTIES:
APPEARANCE:
Liquid blood based vaccine packed in polypropylene
pillow packs
BOILING POINT
No data. Expected to be about 100
0
C
VAPOUR PRESSURE:
No data
SPECIFIC GRAVITY:
Approximately 0.97
FLAMMABILITY:
Does not burn
CORROSIVENESS:
Not corrosive
_TICK FEVER CENTRE, WACOL _
_MSDS TRIVALENT _
MATERIAL SAFETY DATA SHEET
TRIVALENT TICK FEVER VACCINE
_REF: MSDS 3 _
_ _
_ _
Rev: 8
Date of Issue: 17/01/11
Page 2 of 5
OTHER PROPERTIES:
INGREDIENTS:
Contains live attenuated tick fever organisms (
_Babesia bovis_
,
_Babesia bigemina and Anaplasma centrale_
) in bovine blood
diluted with a cell free diluent. The diluent consists of 10%
bovine serum in an isotonic balanced salt solution.
Each 2 mL dose of trivalent vaccine contains:
(i)
Mixed bovine blood containing
_Babesia bovis_
&
_Anaplasma _
_centrale _
_(10_
_7_
_ _
_of _
_each _
_organism)& _
_Babesia bigemina_
(2.5 x 10
6
organisms).
Maximum blood
= 1.20 mL
Minimum blood
= 0.03 mL
Average blood
= 0.26 mL
_ _
_ _
_ _
_ _
_VACCINE DILUENT FORMULATION _
_ _
Sodium Chloride (NaCl)
119.8 mM
Magnesium Chloride (MgCl
2
)
1.5 mM
Glucose (C
6
H
12
O
6
)
5.6 mM
Disodium hydrogen orthophos